OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
Shunshun Bao, Mohammad Darvishi, Ali H. Amin, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7945-7968
Closed Access | Times Cited: 14
Shunshun Bao, Mohammad Darvishi, Ali H. Amin, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7945-7968
Closed Access | Times Cited: 14
Showing 14 citing articles:
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Anticancer activity of Ilex khasiana, a rare and endemic species of holly in Northeast India, against murine lymphoma
Charles Lalnunfela, Pawi Bawitlung Lalthanpuii, Hmar Tlawmte Lalremsanga, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41839-e41839
Open Access
Charles Lalnunfela, Pawi Bawitlung Lalthanpuii, Hmar Tlawmte Lalremsanga, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41839-e41839
Open Access
Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4
Tingting Yang, Dai Shi, Qingyu Lin, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2415-2424
Closed Access | Times Cited: 1
Tingting Yang, Dai Shi, Qingyu Lin, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2415-2424
Closed Access | Times Cited: 1
CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: from interconnected signalling pathways to therapeutic strategies
Brigitte Bauvois, Florence Nguyen‐Khac, Hélène Merle‐Béral, et al.
Biochimie (2024)
Closed Access | Times Cited: 1
Brigitte Bauvois, Florence Nguyen‐Khac, Hélène Merle‐Béral, et al.
Biochimie (2024)
Closed Access | Times Cited: 1
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei
Qidi Zhao, Wei Tian, Ru Ma, et al.
Cancer Biology and Medicine (2024), pp. 1-20
Open Access | Times Cited: 1
Qidi Zhao, Wei Tian, Ru Ma, et al.
Cancer Biology and Medicine (2024), pp. 1-20
Open Access | Times Cited: 1
Exploration of the shared diagnostic genes and mechanisms between periodontitis and primary Sjögren’s syndrome by integrated comprehensive bioinformatics analysis and machine learning
Shaoru Wang, Qimin Wang, Kai Zhao, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112899-112899
Closed Access | Times Cited: 1
Shaoru Wang, Qimin Wang, Kai Zhao, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112899-112899
Closed Access | Times Cited: 1
Jing Tang, Wei Wei, Yanping Xu, et al.
BioFactors (2024)
Closed Access | Times Cited: 1
Rigid Macrocycle Metal Complexes as CXCR4 Chemokine Receptor Antagonists: Influence of Ring Size
Isaline Renard, Thomas D’huys, Benjamin P. Burke, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1000-1000
Open Access
Isaline Renard, Thomas D’huys, Benjamin P. Burke, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1000-1000
Open Access
Impact of SDF-1 and AMD3100 on Hair Follicle Dynamics in a Chronic Stress Model
Yinglin Zhao, Wenzi Liang, Zhehui Liu, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1206-1206
Open Access
Yinglin Zhao, Wenzi Liang, Zhehui Liu, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1206-1206
Open Access
N‐[4‐(Benzyloxy)‐3‐methoxybenzyl)]adamantane‐1‐amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer
Monica Mosaad Rostom, Mariam A. El‐Zohairy, Mohamed A. Marzouk, et al.
Archiv der Pharmazie (2024)
Closed Access
Monica Mosaad Rostom, Mariam A. El‐Zohairy, Mohamed A. Marzouk, et al.
Archiv der Pharmazie (2024)
Closed Access
Immunoexpression of CXCL12 and CXCR4 in oral tongue squamous cell carcinoma of young and older patients
Daniella de Lucena Morais, Luana Samara Balduíno de Sena, John Lennon Silva Cunha, et al.
European Archives of Oto-Rhino-Laryngology (2024)
Closed Access
Daniella de Lucena Morais, Luana Samara Balduíno de Sena, John Lennon Silva Cunha, et al.
European Archives of Oto-Rhino-Laryngology (2024)
Closed Access
Development and therapeutic perspectives of CXCR4 antagonists for disease therapy
Jun Yang, Erkang Tian, Li Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116594-116594
Closed Access
Jun Yang, Erkang Tian, Li Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116594-116594
Closed Access
Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targets
Alessandro Corsaro, Beatrice F. Tremonti, Adriana Bajetto, et al.
Expert Opinion on Therapeutic Targets (2024), pp. 1-16
Closed Access
Alessandro Corsaro, Beatrice F. Tremonti, Adriana Bajetto, et al.
Expert Opinion on Therapeutic Targets (2024), pp. 1-16
Closed Access
Tumor Cell Survival Factors and Angiogenesis in Chronic Lymphocytic Leukemia: How Hot Is the Link?
Marianne Ayoub, Santos A. Susín, Brigitte Bauvois
Cancers (2024) Vol. 17, Iss. 1, pp. 72-72
Open Access
Marianne Ayoub, Santos A. Susín, Brigitte Bauvois
Cancers (2024) Vol. 17, Iss. 1, pp. 72-72
Open Access
